Citation only
via OpenAlex
Abstract 19177: Effect of Aging on Human Mesenchymal Stem Cell Therapy in Ischemic Cardiomyopathy Patients
Samuel Golpanian, Jill Ann El-Khorazaty, Adam M. Mendizabal, Darcy L. DiFede, Wayne Balkan, Joshua M. Hare
Circulation · 2014
Abstract
Background: The role of patient age on the efficacy of mesenchymal stem cell (MSC) therapy in ischemic cardiomyopathy (ICM) is controversial, with some data suggesting a decline in responsiveness with age. We hypothesized that the therapeutic effect of culture expanded MSCs persists even in older subjects. Methods: We divided ICM patients from the TAC-HFT and POSEIDON trials who received MSCs via transendocardial stem cell injection (TESI) into two age groups: <60 yrs vs. ≥ 60 yrs. Functional capacity measures: Six Minute Walking Distance (6MWD) and quality of life measures: Minnesota Living with Heart Failure Questionnaire (MLHFQ) score were compared at baseline, at 6 months and 1 year post-TESI. Cardiac imaging parameters including absolute scar size, ejection fraction (EF), end-diastolic volume (EDV), end-systolic volume (ESV), and sphericity index (SI) were compared at baseline and 1-year post-TESI. Results: Median age of the 49 patients was 63.2 years (range, 32.5-79.0 yrs) with 47% being <60 and 53%...
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- Canonical
- link ↗
- Fetched
- 2026-10-10 MST
Cite this
APA
Golpanian, S., El-Khorazaty, J.A., Mendizabal, A.M., DiFede, D.L., Balkan, W., & Hare, J.M. (2014). Abstract 19177: Effect of Aging on Human Mesenchymal Stem Cell Therapy in Ischemic Cardiomyopathy Patients. <em>Circulation</em>. https://openalex.org/W1564581831
Vancouver
Golpanian S, El-Khorazaty JA, Mendizabal AM, DiFede DL, Balkan W, Hare JM. Abstract 19177: Effect of Aging on Human Mesenchymal Stem Cell Therapy in Ischemic Cardiomyopathy Patients. Circulation. 2014.
BibTeX
@article{samuel2014Abstra,
title = {Abstract 19177: Effect of Aging on Human Mesenchymal Stem Cell Therapy in Ischemic Cardiomyopathy Patients},
author = {Samuel Golpanian and Jill Ann El-Khorazaty and Adam M. Mendizabal and Darcy L. DiFede and Wayne Balkan and Joshua M. Hare},
journal = {Circulation},
year = {2014},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of the American College of Cardiology 2015
Open access · OA
Effect of Aging on Human Mesenchymal Stem Cell Therapy in Ischemic Cardiomyopathy Patients
Stem Cell Reviews and Reports 2020
Open access · OA
Mesenchymal Stem Cell Therapy for COVID-19: Present or Future
Stem cells in clinical applications 2016
Citation only
Mesenchymal Stem Cell Therapy in Rheumatoid Arthritis
Arthritis Research & Therapy 2015
Open access · OA
Update on mesenchymal stem cell-based therapy in lupus and scleroderma
Pharmacological Research 2017
Preprint · CC-BY
Cardiac stem cell aging and heart failure
Transplantation and Cellular Therapy 2013
Open access · CC-BY